微氣泡/超音波造影劑市場規模、佔有率和成長分析（按產品類型、應用、最終用戶、給藥途徑和地區分類）—產業預測（2026-2033 年）

全球微氣泡/超音波造影劑市場規模預計在 2024 年達到 26.2 億美元，從 2025 年的 27.4 億美元成長到 2033 年的 39.3 億美元，在預測期（2026-2033 年）內複合年成長率為 4.6%。

在醫學影像領域，造影對於提高體液和組織結構的可見度至關重要，尤其是在利用微氣泡進行超音波檢查時。這些微氣泡在放射學和心臟病學中用作血池造影劑，具有多種應用，包括基因治療、藥物遞送、分子成像和幹細胞遞送。透過配體分子修飾，微泡可以針對疾病特異性標記物，從而實現對血管狀態的精確監測、發炎成像以及腫瘤血管的評估。靜脈注射的微氣泡模擬循環中的紅血球，並對超音波脈衝做出反應，導致其大小發生動態變化，並在灌注組織中產生強烈的迴聲。這項技術利用氣體和軟組織迴聲強度的差異，顯著增強了超音波診斷和影像對比。

全球微氣泡/超音波造影劑市場促進因素

全球微氣泡/超音波造影劑市場成長的主要驅動力是人們對標靶治療日益成長的興趣以及對精確監測血管內皮生物標記狀態的需求。超音波技術的創新、對精準診斷解決方案不斷成長的需求，以及這些造影劑相對於傳統診斷方法的顯著優勢，預計將推動市場成長。此外，慢性病盛行率的上升也是促進該市場擴張的關鍵因素，因為醫療保健機構正在尋求利用先進影像技術更有效地觀察和診斷健康狀況。

限制全球微氣泡/超音波造影劑市場的因素

全球微氣泡/超音波造影劑市場的主要挑戰之一是微氣泡壽命有限。這一固有特性嚴重限制了其在各種醫療應用中的有效性和效用。由於微氣泡在生物環境中會迅速消散，其短暫性限制了其在長時間成像程序中的應用，阻礙了市場成長。因此，這項限制影響了造影劑的整體應用，因為醫療專業人員正在尋求更持久的替代方案，以便在更長的時間內提供可靠的診斷結果。因此，解決微氣泡保存期限短的問題仍是市場發展的關鍵挑戰。

全球微氣泡/超音波造影市場趨勢

全球微氣泡/超音波造影劑市場正呈現微氣泡創新應用超越傳統影像應用的顯著趨勢。微氣泡泡作為分子影像標靶化劑的新興作用，反映了人們日益認知到其在提高診斷準確性方面的潛力。透過使用能夠特異性結合疾病相關生物標記的配體分子對微泡進行功能化修飾，臨床醫生現在可以更有效地監測各種病理狀況，包括腫瘤血管、發炎和缺血再灌流傷害。隨著醫療機構擴大採用先進的診斷工具來改善患者預後並促進個人化醫療，這種向分子影像應用的轉變預計將推動市場成長。

目錄

介紹

• 調查目標
• 調查範圍
• 定義

調查方法

• 資訊收集
• 一手和二手資料方法
• 市場規模預測
• 市場假設與限制

執行摘要

• 全球市場展望
• 供需趨勢分析
• 細分市場機會分析

市場動態與展望

• 市場規模
• 市場動態
  • 促進因素和機遇
  • 限制與挑戰
• 波特分析

關鍵市場考察

• 關鍵成功因素
• 競爭程度
• 關鍵投資機會
• 市場生態系統
• 市場吸引力指數（2025）
• PESTEL 分析
• 總體經濟指標
• 價值鏈分析
• 定價分析

全球微氣泡/超音波造影劑市場規模（按產品類型和複合年成長率分類）（2026-2033 年）

• 定義
• 歐普蒂森
• 聲波視圖
• 勒梅森
• 其他

全球微氣泡/超音波造影劑市場規模（按應用及複合年成長率分類）（2026-2033 年）

• 心臟病學
• 腫瘤學
• 婦科
• 其他

全球微氣泡/超音波造影劑市場規模（按最終用戶分類）及複合年成長率（2026-2033 年）

• 醫院
• 診斷影像中心
• 專科診所
• 研究和學術機構

全球微氣泡/超音波造影劑市場規模（按給藥途徑和複合年成長率分類）（2026-2033 年）

• 靜脈注射
• 血管內給藥
• 動脈內給藥
• 其他

全球微氣泡/超音波造影劑市場規模及複合年成長率（2026-2033）

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 亞太其他地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲
• 中東和非洲
  • GCC
  • 南非
  • 其他中東和非洲地區

競爭資訊

• 前五大公司對比
• 主要企業的市場定位（2025 年）
• 主要市場參與者所採取的策略
• 近期市場趨勢
• 公司市佔率分析（2025 年）
• 主要企業公司簡介
  • 公司詳情
  • 產品系列分析
  • 依業務板塊進行公司股票分析
  • 2023-2025年營收年比比較

  主要企業簡介

  • Bracco Imaging SpA（義大利）
  • GE醫療（美國）
  • Lantheus Holdings, Inc.（美國）
  • 富士軟片視覺聲學公司（加拿大）
  • 西門子醫療股份公司（德國）
  • 佳能醫療系統株式會社（日本）
  • 三星麥迪遜有限公司（韓國）
  • 邁瑞生物醫療電子有限公司（中國）
  • 飛利浦醫療保健（荷蘭）
  • Advanced Microbubbles Laboratories BV（荷蘭）
  • Targeson公司（美國）
  • VisualSonics（加拿大）
  • NanoMedical Diagnostics, Inc.（美國）
  • 美敦力股份公司（德國）
  • Insightec有限公司（以色列）
  • SuperSonic Imagine SA（法國）
  • 遠距醫療超音波系統（立陶宛）

結論與建議

Global Microbubbles/Ultrasound Contrast Agents Market size was valued at USD 2.62 Billion in 2024 and is poised to grow from USD 2.74 Billion in 2025 to USD 3.93 Billion by 2033, growing at a CAGR of 4.6% during the forecast period (2026-2033).

In the medical imaging sector, contrast agents are essential for enhancing fluid or structural visibility, particularly via microbubbles in ultrasound applications. Serving as blood pool agents in radiology and cardiology, these microbubbles have diverse uses, including gene therapy, drug delivery, molecular imaging, and stem cell delivery. They can be tailored with ligand molecules to target disease-specific markers, enabling precise monitoring of vascular conditions, inflammation imaging, and tumor vasculature assessment. Administered intravenously, microbubbles mimic red blood cells in circulation and respond to ultrasound pulses, creating dynamic variations in size and generating strong echoes from perfused tissue. This technology capitalizes on the differences in echogenicity between gases and soft tissues, significantly enhancing ultrasound diagnosis and imaging contrast.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Microbubbles/Ultrasound Contrast Agents market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Microbubbles/Ultrasound Contrast Agents Market Segments Analysis

Global Microbubbles/Ultrasound Contrast Agents Market is segmented by Product Type, Application Area, End-user, Route of Administration and region. Based on Product Type, the market is segmented into Definity, Optison, Sonovue, Lumason and Others. Based on Application Area, the market is segmented into Cardiology, Oncology, Gynecology and Others. Based on End-user, the market is segmented into Hospitals, Diagnostic Imaging Centers, Specialty Clinics and Research and Academic Institutes. Based on Route of Administration, the market is segmented into Intravenous, Intravascular, Intra-arterial and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Microbubbles/Ultrasound Contrast Agents Market

The Global Microbubbles/Ultrasound Contrast Agents market is propelled by the rising interest in targeted therapies and the necessity to accurately monitor biomarker conditions within the vascular endothelium. The market is expected to experience growth driven by innovations in ultrasound technology, a heightened demand for precise diagnostic solutions, and the distinct advantages these agents offer compared to conventional diagnostic methods. Furthermore, the increasing prevalence of chronic diseases is also a significant factor contributing to this market's expansion, as healthcare providers seek more effective ways to visualize and diagnose health conditions using advanced imaging techniques.

Restraints in the Global Microbubbles/Ultrasound Contrast Agents Market

One significant challenge facing the Global Microbubbles/Ultrasound Contrast Agents market is the limited lifespan of microbubbles. This inherent property poses a considerable limitation, hindering their effectiveness and utility in various medical applications. As microbubbles dissipate quickly in biological environments, their transient nature can restrict their use in prolonged imaging procedures, ultimately impeding the growth of the market. Consequently, this limitation affects the overall adoption of these contrast agents, as healthcare providers seek more durable alternatives that can provide reliable diagnostic results over extended periods. Thus, addressing the short duration of microbubble efficacy remains a crucial hurdle for market development.

Market Trends of the Global Microbubbles/Ultrasound Contrast Agents Market

The Global Microbubbles/Ultrasound Contrast Agents market is witnessing a significant trend towards the innovative utilization of microbubbles beyond traditional imaging applications. Their emerging role as targeted agents for molecular imaging reflects a growing recognition of their potential in enhancing diagnostic precision. By functionalizing microbubbles with ligand molecules that specifically bind to disease-related biomarkers, clinicians can now monitor various conditions such as tumor vasculature, inflammation, and ischemia-reperfusion injuries more effectively. This shift towards molecular imaging applications is expected to drive market growth, as healthcare providers increasingly adopt advanced diagnostic tools that improve patient outcomes and facilitate personalized medicine.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2025
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis

Global Microbubbles/Ultrasound Contrast Agents Market Size by Product Type & CAGR (2026-2033)

• Market Overview
• Definity
• Optison
• Sonovue
• Lumason
• Others

Global Microbubbles/Ultrasound Contrast Agents Market Size by Application Area & CAGR (2026-2033)

• Market Overview
• Cardiology
• Oncology
• Gynecology
• Others

Global Microbubbles/Ultrasound Contrast Agents Market Size by End-user & CAGR (2026-2033)

• Market Overview
• Hospitals
• Diagnostic Imaging Centers
• Specialty Clinics
• Research and Academic Institutes

Global Microbubbles/Ultrasound Contrast Agents Market Size by Route of Administration & CAGR (2026-2033)

• Market Overview
• Intravenous
• Intravascular
• Intra-arterial
• Others

Global Microbubbles/Ultrasound Contrast Agents Market Size & CAGR (2026-2033)

• North America (Product Type, Application Area, End-user, Route of Administration)
  • US
  • Canada
• Europe (Product Type, Application Area, End-user, Route of Administration)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product Type, Application Area, End-user, Route of Administration)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product Type, Application Area, End-user, Route of Administration)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product Type, Application Area, End-user, Route of Administration)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2025
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2025
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2023-2025)

Key Company Profiles

• Bracco Imaging S.p.A. (Italy)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• GE Healthcare (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Lantheus Holdings, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• FUJIFILM VisualSonics, Inc. (Canada)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Siemens Healthineers AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Canon Medical Systems Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Samsung Medison Co., Ltd. (South Korea)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Mindray Bio-Medical Electronics Co., Ltd. (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Philips Healthcare (Netherlands)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Advanced Microbubbles Laboratories B.V. (Netherlands)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Targeson, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• VisualSonics (Canada)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• NanoMedical Diagnostics, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medtron AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Insightec Ltd. (Israel)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• SuperSonic Imagine S.A. (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Telemed Ultrasound Systems (Lithuania)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations